Osteogenic Sarcoma

A STUDY OF SIX HUNDRED CASES

¹ From the Section of Surgical Pathology and of Orthopedic Surgery, Mayo Clinic and Mayo Foundation, Rochester

Of 600 patients with pathologically verified osteogenic sarcoma (exclusive of tumors of the jaws and parosteal osteogenic sarcoma), 410 were eligible for five-year follow-up and 408 were traced. Of the 408 patients, eighty-three (20.3 per cent) survived more than five years. The survival rate (17.1 per cent) for patients whose tumors were predominantly osteoblastic was lower, but not to a statistically significant degree, than the rate for those with chondroblastic or fibroblastic tumors. More than 25 per cent of those with tumors in the more readily treatable sites, namely distal to the proximal end of the humerus or femur, survived five years. Sex had little bearing on prognosis. The more anaplastic sarcomata were associated with a poorer prognosis than the average, but again the difference was not statistically significant. Two patients survived long intervals after resection for pulmonary metastasis.

Twenty of the 600 patients had osteogenic sarcoma that developed in lesions of Paget's disease, and three of these became long-term survivors. Sixteen had osteogenic sarcoma that arose in bones that had been irradiated previously; none of these survived more than three years. The possibility of multicentric origin of osteogenic sarcoma arose in sixteen patients.

It is concluded that vigorous, prompt treatment should be employed for osteogenic sarcoma and a gratifying number of survivors obtained.

CiteULike    Connotea    Del.icio.us    Facebook    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. J. Messerschmitt, R. M. Garcia, F. W. Abdul-Karim, E. M. Greenfield, and P. J. Getty Osteosarcoma J. Am. Acad. Ortho. Surg., August 1, 2009; 17(8): 515 - 527. [Abstract] [Full Text] [PDF]

				T. Zwaga, J. V. M. G. Bovee, and H. M. Kroon Best Cases from the AFIP: Osteosarcoma of the Femur with Skip, Lymph Node, and Lung Metastases RadioGraphics, January 1, 2008; 28(1): 277 - 283. [Full Text] [PDF]

				Y. Cao, Z. Zhou, B. de Crombrugghe, K. Nakashima, H. Guan, X. Duan, S.-F. Jia, and E. S. Kleinerman Osterix, a Transcription Factor for Osteoblast Differentiation, Mediates Antitumor Activity in Murine Osteosarcoma Cancer Res., February 15, 2005; 65(4): 1124 - 1128. [Abstract] [Full Text] [PDF]

				M. D. Murphey, J. S. Jelinek, H. T. Temple, D. J. Flemming, and F. H. Gannon Imaging of Periosteal Osteosarcoma: Radiologic-Pathologic Comparison Radiology, October 1, 2004; 233(1): 129 - 138. [Abstract] [Full Text] [PDF]

				N. Marina, M. Gebhardt, L. Teot, and R. Gorlick Biology and Therapeutic Advances for Pediatric Osteosarcoma Oncologist, July 1, 2004; 9(4): 422 - 441. [Abstract] [Full Text] [PDF]

				A. P. Shah, S. Parmar, and R. O'Regan Right Atrial and Ventricular Thrombus Infiltrated with Osteoblastic Osteosarcoma Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 307 - 311. [Abstract] [PDF]

				L. Aung, R. Gorlick, J. H. Healey, W. Shi, H. T. Thaler, N. A. Shorter, A. G. Huvos, and P. A. Meyers Metachronous Skeletal Osteosarcoma in Patients Treated with Adjuvant and Neoadjuvant Chemotherapy for Nonmetastatic Osteosarcoma J. Clin. Oncol., January 15, 2003; 21(2): 342 - 348. [Abstract] [Full Text] [PDF]

				K. Honoki, T. Tsujiuchi, M. Tsutsumi, A. Kido, T. Morishita, M. Yoshimoto, Y. Miyauchi, Y. Mii, S. Tamai, and Y. Konishi Possible Involvement of bcl-2 Suppression in Wild-Type p53 Gene-Dependent Cell Growth Repression in Rat Osteosarcoma Cells Toxicol Pathol, July 1, 2000; 28(4): 575 - 579. [Abstract] [PDF]

				B. Widhe and T. Widhe Initial Symptoms and Clinical Features in Osteosarcoma and Ewing Sarcoma J. Bone Joint Surg. Am., May 1, 2000; 82(5): 667 - 667. [Abstract] [Full Text]

				D. A. SPIEGEL, W. J. RICHARDSON, S. P. SCULLY, and J. M. HARRELSON Long-Term Survival Following Total Sacrectomy with Reconstruction for the Treatment of Primary Osteosarcoma of the Sacrum. A Case Report J. Bone Joint Surg. Am., June 1, 1999; 81(6): 848 - 55. [Full Text]

				D. Sudilovsky, J. O. Johnston, and C. Zaloudek Intracortical Osteosarcoma: A Case Report and Review of the Literature International Journal of Surgical Pathology, January 1, 1996; 3(3): 195 - 200. [Abstract] [PDF]

				M. S. Brady, J. J. Gaynor, and M. F. Brennan Radiation-Associated Sarcoma of Bone and Soft Tissue Arch Surg, December 1, 1992; 127(12): 1379 - 1385. [Abstract] [PDF]

				L. J. Loescher, D. Welch-McCaffrey, S. A. Leigh, B. Hoffman, and F. L. Meyskens Jr Surviving Adult Cancers. Part 1: Physiologic Effects Ann Intern Med, September 1, 1989; 111(5): 411 - 432. [Abstract] [PDF]

				J. F. Huth and F. R. Eilber Patterns of Recurrence After Resection of Osteosarcoma of the Extremity: Strategies for Treatment of Metastases Arch Surg, January 1, 1989; 124(1): 122 - 126. [Abstract] [PDF]

				D. M. PARRY, J. J. MULVIHILL, R. W. MILLER, and R. J. SPIEGEL Sarcomas in a Child and Her Father: An Etiologic Consultation Arch Pediatr Adolesc Med, February 1, 1979; 133(2): 130 - 132. [Abstract] [PDF]

				A. Sybert and T. P. Butler Sarcoidosis Following Adjuvant High-Dose Methotrexate Therapy for Osteosarcoma Arch Intern Med, March 1, 1978; 138(3): 488 - 489. [Abstract] [PDF]

				J. Wilimas, G. Barrett, and C. Pratt Osteosarcoma in 2 Very Young Children Clinical Pediatrics, June 1, 1977; 16(6): 548 - 551. [PDF]

				E. P. Cortes, J. F. Holland, J. J. Wang, and L. F. Sinks Doxorubicin in Disseminated JAMA, September 4, 1972; 221(10): 1132 - 1138. [Abstract] [PDF]

				J. S. Nosanchuk, L. Weatherbee, and G. L. Brody Osteogenic Sarcoma: Prognosis Related to Epiphyseal Closure JAMA, June 30, 1969; 208(13): 2439 - 2441. [Abstract] [PDF]